• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.78% Nasdaq Down1.13%

    22nd Century Group, Inc. (XXII)

    -NYSE MKT
    0.83 Down 0.01(0.61%) 4:00PM EDT
    ProfileGet Profile for:
    22nd Century Group, Inc.
    9530 Main Street
    Clarence, NY 14031
    United States - Map
    Phone: 716-270-1523
    Fax: 716-877-3064
    Website: http://www.xxiicentury.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:39

    Business Summary 

    22nd Century Group, Inc., a plant biotechnology company, provides technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants to be decreased or increased through genetic engineering and plant breeding. It develops smoking cessation products and modified risk tobacco products for smokers who are unable or unwilling to quit smoking and who may be interested in cigarettes, which reduce exposure to nicotine or to certain tobacco smoke toxins and/or pose a lower health risk than conventional cigarettes. The company’s products include RED SUN and MAGIC regular and menthol cigarettes; and SPECTRUM government research cigarettes. It is also developing X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy; and modified risk cigarettes, such as BRAND A, which has approximately 95% less nicotine than conventional tobacco cigarettes, as well as BRAND B cigarettes that contain low amount of tar per milligram of nicotine. The company was founded in 1998 and is headquartered in Clarence, New York.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on 22nd Century Group, Inc.

    Corporate Governance 
    22nd Century Group, Inc.’s ISS Governance QuickScore as of Jul 1, 2015 is 9. The pillar scores are Audit: 10; Board: 8; Shareholder Rights: 6; Compensation: 6.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Henry Sicignano III, MBA, 48
    Chief Exec. Officer, Pres, Director and Member of Scientific, Technical Advisory & Support Committee
    249.00K0.00
    Mr. John T. Brodfuehrer , 58
    Chief Financial Officer and Treasurer
    171.00K0.00
    Mr. Thomas L. James Esq., 57
    VP, Gen. Counsel and Sec.
    296.00K0.00
    Dr. Michael R. Moynihan Ph.D., 63
    VP of R&D
    174.00K0.00
    Mr. Gregg M. Gellman ,
    Director of Bus. Devel. & Regulatory Affairs
    N/AN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders